세계 요로결석 질환 ​​시장 – 2023-2030

Global Stone Disease Market - 2023-2030

상품코드MDP7775
발행기관DataM Intelligence
발행일2024.01.18
페이지 수185 Pages
포맷PDF + EXCEL
커버리지Global

₩6,525,000 – ₩11,775,000

보고서 요약(국문)

개요
전 세계 신장 결석 질환 ​​시장은 2022년 XX억 달러에 달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률로 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
신장 결석 질환 ​​또는 요로 결석증은 신장 내부에 형성되는 미네랄과 염분으로 이루어진 단단한 침전물입니다. 이는 신장, 방광 및 요로에서 결석이 생성되는 것을 특징으로 합니다. 위에서 언급한 부위에 결석이 형성되는 주된 원인은 소변량 감소와 옥살산염, 칼슘, 시스테인, 요산염, 인산염 및 크산틴과 같은 결석 형성 물질의 배설량 증가입니다.
신장 결석은 현대적인 시술, 관련 의료 기술 및 신장 결석 관리 기기의 사용으로 효과적으로 치료할 수 있습니다. 신장 결석 질환은 체외충격파쇄석술, 요관경술 및 경피적 신석제거술과 같은 의료 시술을 통해 널리 치료됩니다.

시장 동향
신장 결석 유병률 증가
새로운 제품 출시가 증가하면서 시장 성장이 가속화되고 있습니다. 신장 결석은 농축된 소변에 미네랄과 산성염이 뭉쳐 생긴 단단한 침전물입니다. 단백질, 나트륨, 당분이 많은 식단은 특정 유형의 신장 결석 발생 위험을 높일 수 있습니다.
예를 들어, 캐나다 신장 재단(Kidney Foundation of Canada)에 따르면 캐나다에서 신장 결석은 흔하며 지난 25년간 증가 추세를 보이고 있습니다. 남성의 약 12%, 여성의 약 6%가 일생 동안 한 번쯤 신장 결석을 경험합니다. 남성의 경우 첫 신장 결석 진단은 보통 40~60세 사이에 이루어집니다.
또한, 2021년 국제 분자 의학 저널(International Journal of Molecular Medicine)에 발표된 자료에 따르면 중국 성인의 신장 결석 유병률은 5.8%(남성 6.5%, 여성 5.1%)로, 현재 성인 17명 중 1명꼴로 영향을 받고 있습니다.

또한, 최소 침습 시술에 대한 수요 증가와 요관경술 기술의 발전과 같은 주요 성장 동력이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
경피적 신석제거술 관련 부작용
신장 결석 질환의 발생률이 증가하고 있음에도 불구하고, 몇 가지 요인이 치료 도입을 제한하고 있습니다. 시장 성장을 저해하는 주요 요인 중 하나는 신장 주변 출혈, 파쇄된 결석으로 인한 요로 폐쇄, 감염, 동맥혈압 상승 등과 같은 부작용입니다. 이러한 합병증은 예측 기간 동안 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
세계 신장 결석 질환 ​​시장은 유형, 치료, 판매 채널 및 지역별로 세분화됩니다.
충격파 쇄석술 부문은 시장 점유율의 약 49.1%를 차지했습니다.
충격파 쇄석술 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 쇄석술은 투시 또는 초음파로 먼저 위치를 확인한 결석에 집중된 초음파 에너지 또는 충격파를 직접 전달하여 신장 결석을 치료합니다. 충격파는 큰 결석을 작은 결석으로 부수어 요로를 통해 배출되도록 합니다.
2021년 리서치 스퀘어(Research Square) 보고서에 따르면, 칼슘 결석이 모든 국가에서 가장 흔했으며(최대 91%), 캐나다와 중국에서 발생률이 가장 높았습니다. 이집트와 인도를 제외한 국가에서는 옥살산 결석이 인산염 또는 인산염/옥살산 혼합 결석보다 더 흔했습니다. 요산 결석은 이집트, 인도, 파키스탄, 이라크, 폴란드, 불가리아에서 더 흔합니다.
예를 들어, 2021년 2월 쇼크웨이브 메디컬(Shockwave Medical, Inc.)은 미국 FDA로부터 심하게 석회화된 관상동맥 질환에 대한 시판 전 승인을 받았습니다. FDA로부터 혁신 의료기기(Breakthrough Device) 지정을 받은 이 혁신적인 기술은 수십 년 동안 신장 결석을 안전하게 파쇄하는 데 사용되어 온 체외충격파쇄석술의 새로운 응용 분야입니다. 따라서 이러한 요인들로 인해 해당 분야는 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

지리적 분석
북미는 전 세계 신장결석 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
북미는 신장결석 유병률 증가 및 의료비 지출 증가와 같은 요인으로 인해 상당한 시장 점유율을 유지해 왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 미국 국립보건원(NIH)의 2023년 보고서에 따르면, 신장결석의 유병률과 재발률이 증가하고 있으며, 효과적인 약물 및 시술 옵션이 제한적인 상황에서 전 세계 인구의 약 12%가 신장결석으로 고통받고 있습니다. 미국에서는 20세에서 49세 사이의 신장결석 환자가 매년 약 60만 명으로 추산됩니다.
또한, 미국 신장재단(National Kidney Foundation)에 따르면, 미국에서는 매년 50만 명 이상이 신장결석으로 인해 응급실을 방문합니다. 통계에 따르면, 미국의 환자 수 증가와 가처분 소득 증가는 이 지역 시장 성장을 촉진하고 있습니다.
코로나19 영향 분석
코로나19 팬데믹은 전 세계 신장결석 시장에 상당한 영향을 미쳤습니다. 2020년 초 팬데믹 발생으로 인해 광범위한 봉쇄와 제한 조치가 시행되었고, 이는 전 세계적으로 정기적인 진단, 치료, 제품 출시 및 상담에 영향을 미쳤습니다. 팬데믹 발생으로 인해 많은 제약 회사나 의료기기 제조업체는 인력 부족에 직면했고, 봉쇄 조치로 인해 직원들이 출근하지 못하는 상황이 발생했습니다. 따라서 이러한 요인들로 인해 요로결석 시장은 예측 기간 동안 다소 영향을 받을 것으로 예상됩니다.
시장 세분화
유형별
• 옥살산칼슘
• 요산
• 스트루바이트
• 시스틴
치료법별
• 약물
o 알파 차단제
 탐술로신
 알푸조신
 실로도신
 나프토피딜
o 티아지드 이뇨제
 히드로클로로티아지드
 클로르탈리돈
 인다파미드
o 알로푸리놀
• 수술
o 체외충격파쇄석술(SWL)
o 요관경술
o 경피적 신석제거술(PCNL)
• 의료기기
o 쇄석기
o 요관 스텐트
o 요관경
판매 채널별
• 유통 채널
o 병원 약국
o 소매 약국
o 온라인 약국
• 최종 사용자
o 병원
o 외래 수술 센터
o 전문 클리닉
o 기타
지역별
• 북미
o • 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Boston Scientific Corporation, Becton Dickinson and Company, Cook Medical Inc., Olympus Corporation, Storz Medical AG, Richard Wolf GmbH, Dornier MedTech GmbH, DirexGroup, Stryker Corporation, Zhuhai Shixin Medical Technology Co.Ltd 등이 있습니다.

주요 개발 사항
• 2023년 2월, Boston Scientific은 LithoVue Elite 일회용 디지털 연성 요관경 시스템에 대해 FDA 승인을 받았습니다. 이 시스템은 신장 결석 시술 중 실시간 임상 결정을 지원하도록 설계되었습니다.

• 2022년 7월, Calyxo는 신장 ​​결석 제거를 위해 관류 및 흡인 방식을 사용하는 CVAC 흡인 시스템 개발을 위해 3,270만 달러를 투자 유치했습니다. 이 시스템은 수술 없이 결석을 제거하는 것을 목표로 합니다.

보고서 구매 이유:

• 유형, 치료법, 판매 채널 및 지역별 글로벌 신장 결석 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 글로벌 신장 결석 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 신장 결석 시장 보고서는 약 61개의 표, 59개의 그림, 185페이지 분량입니다.
2023년 주요 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Stone Disease Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Stone disease or urolithiasis are hard deposits made of minerals and salts that form inside the kidneys. It is characterized by stone production in the kidney, bladder, and urinary tract. Stone formation in the locations mentioned above is mostly caused by decreased urine volume and increased excretion of stone-forming chemicals such as oxalate, calcium, cysteine, urate, phosphate, and xanthine.
Kidney stones can be effectively treated due to the availability of modern procedures, accompanying medical technologies, and kidney stone management devices. Stone disease is widely treated by medical procedures namely shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy.
Market Dynamics
Increasing prevalence of kidney stones
The increasing product launches act as a significant driver for market growth. Kidney stones are hard deposits of minerals and acid salts that stick together in concentrated urine. Eating a diet that is high in protein, sodium and sugar can increase the risk of some types of kidney stones.
For instance, according to the Kidney Foundation of Canada, kidney stones are common in Canada and appear to be on the rise over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life. In men, the first kidney stone is usually diagnosed between the ages of 40 and 60.
Also, according to the International Journal of Molecular Medicine published in 2021, the prevalence of kidney stones was 5.8% among Chinese adults (6.5% in men and 5.1% in women), with about 1 in 17 adults currently affected.
Furthermore, significant growth drivers such as rising demand for minimally invasive procedures, and advancements in ureteroscopy techniques are expected to drive the market in the forecast period.
Side effects related to percutaneous nephrolithotomy
Despite the increasing incidence of stone diseases, certain factors limit the adoption of its treatment. One of the major factors obstructing the market's growth is its side effects, such as bleeding around the kidneys, blockage of urine due to broken stones, infections, and an increase in arterial blood pressure, among others. These complications are expected to hinder the market growth during the forecast period.
Segment Analysis
The global stone disease market is segmented based on type, treatment, sales channel and region.
The shockwave lithotripsy segment accounted for approximately 49.1% of the market share
The shockwave lithotripsy segment is expected to hold the largest market share over the period forecast. Lithotripsy treats kidney stones by sending focused ultrasonic energy or shock waves directly to the stone first located with fluoroscopy or ultrasound. The shock waves break a large stone into smaller stones that will pass through the urinary system.
According to the Research Square Article, 2021, calcium stones were the most common in all countries (up to 91%), with Canada and China having the highest incidence. Except in Egypt and India, oxalate stones were more common than phosphate or mixed phosphate/oxalate stones. Uric acid stones are more common in Egypt, India, Pakistan, Iraq, Poland, and Bulgaria.
For instance, in February 2021, Shockwave Medical, Inc. received Pre-Market Approval for severely calcified coronary artery disease from the U.S. FDA. The innovative technology, which was granted Breakthrough Device designation by the FDA, is a novel application of lithotripsy, an approach that has been used for decades to safely break up kidney stones. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global stone disease market share
North America has maintained a significant market proportion due to factors such as the rising prevalence of nephrolithiasis, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, according to the National Institute of Health Report 2023, the prevalence and recurrence rates of nephrolithiasis are increasing, with limited options of effective drugs and procedures, affecting about 12% of the population worldwide. The incidence is estimated at 600,000 in the U.S. Between the ages of 20 to 49.
Additionally, in the United States, kidney stones send more than 500,000 people to the emergency room each year, as stated by the National Kidney Foundation. As per the statistics, the increasing patient pool and disposable revenue in this country boost the region's market growth.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global stone disease market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatment, product launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the stone disease market is expected to be moderately affected over the forecast period.
Market Segmentation
By Type
• Calcium oxalate
• Uric acid
• Struvite
• Cystine
By Treatment
• Medications
o Alpha Blockers
 tamsulosin
 alfuzosin
 silodosin
 naftopidil
o Thiazide Diuretics
 Hydrochlorothiazide
 Chlorthalidone
 Indapamide
o Allopurinol
• Surgery
o Shockwave Lithotripsy (SWL)
o Ureteroscopy
o Percutaneous Nephrolithotomy (PCNL)
• Device
o Lithotripters
o Ureteral Stents
o Ureterorenoscope
By Sales Channel
• Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• End User
o Hospitals
o Ambulatory Surgical Centers
o Specialty Clinics
o Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Boston Scientific Corporation, Becton Dickinson and Company, Cook Medical Inc., Olympus Corporation, Storz Medical AG, Richard Wolf GmbH, Dornier MedTech GmbH, DirexGroup, Stryker Corporation, Zhuhai Shixin Medical Technology Co.Ltd among others.
Key Developments
• In February 2023, Boston Scientific received FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System. It is designed to inform real-time clinical decisions during kidney stone procedures.
• In July 2022, Calyxo raised $32.7M for the CVAC Aspiration system designed to use irrigation and aspiration to remove kidney stones with the goal of a surgically stone-free outcome.
Why Purchase the Report?
• To visualize the global stone disease market segmentation based on type, treatment, sales channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global stone disease market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global stone disease market report would provide approximately 61 tables, 59 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Treatment
3.3. Snippet by Sales Channel
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of kidney stones
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Side effects related to percutaneous nephrolithotomy
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Calcium oxalate*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Uric acid
7.4. Struvite
7.5. Cystine
8. By Treatment
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
8.1.2. Market Attractiveness Index, By Treatment
8.2. Medications*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Alpha Blockers
8.2.3.1. tamsulosin
8.2.3.2. alfuzosin
8.2.3.3. silodosin
8.2.3.4. naftopidil
8.2.4. Thiazide Diuretics
8.2.4.1. Hydrochlorothiazide
8.2.4.2. Chlorthalidone
8.2.4.3. Indapamide
8.2.5. Allopurinol
8.3. Surgery
8.3.1. Shockwave Lithotripsy (SWL)
8.3.2. Ureteroscopy
8.3.3. Percutaneous Nephrolithotomy (PCNL)
8.4. Device
8.4.1. Lithotripters
8.4.2. Ureteral Stents
8.4.3. Ureterorenoscope
9. By Sales Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.1.2. Market Attractiveness Index, By Sales Channel
9.2. Distribution Channel*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.2.3. Hospital Pharmacy
9.2.4. Retail Pharmacy
9.2.5. Online Pharmacy
9.3. End User
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.3.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Boston Scientific Corporation
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Becton Dickinson and Company
12.3. Cook Medical Inc.
12.4. Olympus Corporation
12.5. Storz Medical AG
12.6. Richard Wolf GmbH
12.7. Dornier MedTech GmbH
12.8. DirexGroup
12.9. Stryker Corporation
12.10. Zhuhai Shixin Medical Technology Co.Ltd
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Boston Scientific Corporation, 4. Key Developments, Becton Dickinson and Company, Cook Medical Inc., Olympus Corporation, Storz Medical AG, Richard Wolf GmbH, Dornier MedTech GmbH, DirexGroup, Stryker Corporation, Zhuhai Shixin Medical Technology Co.Ltd

표 목록 (Tables)

List of Tables

Table 1 Global Stone Disease Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Stone Disease Market Value, By Treatment, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Stone Disease Market Value, By Sales Channel, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Stone Disease Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Stone Disease Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 7 Global Stone Disease Market Value, By Treatment, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 9 Global Stone Disease Market Value, By Sales Channel, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 11 Global Stone Disease Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Stone Disease Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 14 North America Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 15 North America Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 16 North America Stone Disease Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 18 South America Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 19 South America Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 20 South America Stone Disease Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 22 Europe Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 23 Europe Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 24 Europe Stone Disease Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Stone Disease Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Stone Disease Market Value, By Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Stone Disease Market Value, By Treatment, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Stone Disease Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 32 Boston Scientific Corporation: Overview

Table 33 Boston Scientific Corporation: Product Portfolio

Table 34 Boston Scientific Corporation: Key Developments

Table 35 Becton Dickinson and Company: Overview

Table 36 Becton Dickinson and Company: Product Portfolio

Table 37 Becton Dickinson and Company: Key Developments

Table 38 Cook Medical Inc.: Overview

Table 39 Cook Medical Inc.: Product Portfolio

Table 40 Cook Medical Inc.: Key Developments

Table 41 Olympus Corporation: Overview

Table 42 Olympus Corporation: Product Portfolio

Table 43 Olympus Corporation: Key Developments

Table 44 Storz Medical AG: Overview

Table 45 Storz Medical AG: Product Portfolio

Table 46 Storz Medical AG: Key Developments

Table 47 Richard Wolf GmbH: Overview

Table 48 Richard Wolf GmbH: Product Portfolio

Table 49 Richard Wolf GmbH: Key Developments

Table 50 Dornier MedTech GmbH: Overview

Table 51 Dornier MedTech GmbH: Product Portfolio

Table 52 Dornier MedTech GmbH: Key Developments

Table 53 DirexGroup: Overview

Table 54 DirexGroup: Product Portfolio

Table 55 DirexGroup: Key Developments

Table 56 Stryker Corporation: Overview

Table 57 Stryker Corporation: Product Portfolio

Table 58 Stryker Corporation: Key Developments

Table 59 Zhuhai Shixin Medical Technology Co.Ltd: Overview

Table 60 Zhuhai Shixin Medical Technology Co.Ltd: Product Portfolio

Table 61 Zhuhai Shixin Medical Technology Co.Ltd: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 2 Global Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 3 Global Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 4 Global Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 5 Global Stone Disease Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Stone Disease Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 7 Calcium oxalate  Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 8 Uric acid  Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 9 Struvite Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 10 Cystine Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 11 Global Stone Disease Market Y-o-Y Growth, By Treatment, 2022-2030 (%)

Figure 12 Medications Treatment in Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 13 Surgery Treatment in Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 14 Device Treatment in Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 15 Global Stone Disease Market Y-o-Y Growth, By Sales Channel, 2022-2030 (%)

Figure 16 Distribution Channel Sales Channel in Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 17 End User Sales Channel in Global Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 18 Global Stone Disease Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 19 North America Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 20 Asia-Pacific Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 21 Europe Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 22 South America Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 23 Middle East and Africa Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 24 North America Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 25 North America Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 26 North America Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 27 North America Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 28 North America Stone Disease Market Share, By Country, 2022 & 2030 (%)

Figure 29 South America Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 30 South America Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 31 South America Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 32 South America Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 33 South America Stone Disease Market Share, By Country, 2022 & 2030 (%)

Figure 34 Europe Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 35 Europe Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 36 Europe Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 37 Europe Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 38 Europe Stone Disease Market Share, By Country, 2022 & 2030 (%)

Figure 39 Asia-Pacific Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 40 Asia-Pacific Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 41 Asia-Pacific Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 42 Asia-Pacific Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 43 Asia-Pacific Stone Disease Market Share, By Country, 2022 & 2030 (%)

Figure 44 Middle East & Africa Stone Disease Market Value, 2021-2030 (US$ Million)

Figure 45 Middle East & Africa Stone Disease Market Share, By Type, 2022 & 2030 (%)

Figure 46 Middle East & Africa Stone Disease Market Share, By Treatment, 2022 & 2030 (%)

Figure 47 Middle East & Africa Stone Disease Market Share, By Sales Channel, 2022 & 2030 (%)

Figure 48 Boston Scientific Corporation: Financials

Figure 49 Becton Dickinson and Company: Financials

Figure 50 Cook Medical Inc.: Financials

Figure 51 Olympus Corporation: Financials

Figure 52 Storz Medical AG: Financials

Figure 53 Richard Wolf GmbH: Financials

Figure 54 Dornier MedTech GmbH: Financials

Figure 55 DirexGroup: Financials

Figure 56 Stryker Corporation: Financials

Figure 57 Zhuhai Shixin Medical Technology Co.Ltd: Financial